Large-Cap Stocks Underperform: Synopsys, Chewy, Trade Desk Among Top 10 Losers
ByAinvest
Monday, Sep 15, 2025 2:17 am ET1min read
CHWY--
Synopsys, a leading provider of chip design software, saw its stock plunge 29.20% following the release of its third-quarter results. The company reported revenue of $1.74 billion, falling short of analyst estimates of $1.77 billion. Adjusted earnings per share (EPS) also missed expectations, coming in at $3.39 compared to the anticipated $3.74. The underperformance was primarily attributed to weaknesses in the Design IP business, including disrupted design starts in China, challenges at a major foundry customer, and internal roadmap issues [1].
Chewy, a popular online pet supply retailer, saw its stock drop 18.05% after reporting second-quarter results. Despite revenue and EPS meeting expectations, the company's 79% fall in net profit and less-than-expected investment into the business raised concerns. JP Morgan maintained its 'Overweight' rating on Chewy stock but noted that the over 16% drop was an overreaction to the company's financials. The company's full-year sales forecast was also boosted, but the stock's decline was attributed to margin compression worries [2].
The Trade Desk, a digital ad tech company, faced a 13.75% decline after Morgan Stanley downgraded its stock to "equal weight" from "overweight." The downgrade was driven by mounting concerns about the company's connected TV business, which has been facing headwinds. Morgan Stanley cited their past mistakes in predicting the company's growth [3].
Other large-cap stocks that lost value include Summit Therapeutics, Rubrik, BioNTech, Ferguson Enterprises, Humana, Samsara, and Burlington Stores. These companies also reported financial results that fell short of expectations or faced negative analyst commentary.
Investors should closely monitor these large-cap stocks for any signs of recovery or further declines. The recent sell-off highlights the importance of staying informed about company-specific events and market trends.
SNPS--
TTD--
Large-cap stocks Synopsys, Chewy, and The Trade Desk lost 29.20%, 18.05%, and 13.75% respectively last week. The losses were attributed to worse-than-expected financial results, lower price forecasts, and a downgrade from Morgan Stanley. Other large-cap stocks that lost value include Summit Therapeutics, Rubrik, BioNTech, Ferguson Enterprises, Humana, Samsara, and Burlington Stores.
Large-cap stocks Synopsys (SNPS), Chewy (CHWY), and The Trade Desk (TTD) experienced significant losses last week, with declines of 29.20%, 18.05%, and 13.75% respectively. The sell-off was driven by a combination of worse-than-expected financial results, lower price forecasts, and downgrades from investment firms.Synopsys, a leading provider of chip design software, saw its stock plunge 29.20% following the release of its third-quarter results. The company reported revenue of $1.74 billion, falling short of analyst estimates of $1.77 billion. Adjusted earnings per share (EPS) also missed expectations, coming in at $3.39 compared to the anticipated $3.74. The underperformance was primarily attributed to weaknesses in the Design IP business, including disrupted design starts in China, challenges at a major foundry customer, and internal roadmap issues [1].
Chewy, a popular online pet supply retailer, saw its stock drop 18.05% after reporting second-quarter results. Despite revenue and EPS meeting expectations, the company's 79% fall in net profit and less-than-expected investment into the business raised concerns. JP Morgan maintained its 'Overweight' rating on Chewy stock but noted that the over 16% drop was an overreaction to the company's financials. The company's full-year sales forecast was also boosted, but the stock's decline was attributed to margin compression worries [2].
The Trade Desk, a digital ad tech company, faced a 13.75% decline after Morgan Stanley downgraded its stock to "equal weight" from "overweight." The downgrade was driven by mounting concerns about the company's connected TV business, which has been facing headwinds. Morgan Stanley cited their past mistakes in predicting the company's growth [3].
Other large-cap stocks that lost value include Summit Therapeutics, Rubrik, BioNTech, Ferguson Enterprises, Humana, Samsara, and Burlington Stores. These companies also reported financial results that fell short of expectations or faced negative analyst commentary.
Investors should closely monitor these large-cap stocks for any signs of recovery or further declines. The recent sell-off highlights the importance of staying informed about company-specific events and market trends.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet